Unadjusted and adjusted factors associated with all-cause mortality among HIV-positive injection drug users initiating highly active antiretroviral therapy in British Columbia, between June 1998 and Sept 2011 (n = 254).

1<p>Hazard Ratio</p>2<p>95% Confidence Interval</p>3<p>Adjusted Hazard Ratio</p>4<p>Highly active antiretroviral therapy</p>5<p>Protease Inhibitor</p>6<p>Within the last 12 months of interview</p

Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users initiating antiretroviral therapy in British Columbia, stratified by hunger status.

<p>Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users initiating antiretroviral therapy in British Columbia, stratified by hunger status.</p

Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users initiating antiretroviral therapy in British Columbia, stratified by food security status.

<p>Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users initiating antiretroviral therapy in British Columbia, stratified by food security status.</p

Baseline characteristics among HIV-positive injection drug users initiating antiretroviral therapy across British Columbia, by food security status, between June 1998 and Sept 2011 (n = 254).

1<p>Inter-quartile range</p>2<p>Highly active antiretroviral therapy use</p>3<p>Protease Inhibitor-based regimen</p>4<p>Within last 12 months of interview</p

Rates of new HIV-related diagnoses and deaths in Canada.

<p><b>Panel A</b>: New HIV-positive cases, by region, 1995–2008. <b>Panel B</b>: HIV-related deaths, by region, 1995–2008.</p

Data sources used in this study spanning the period 1995 to 2008.

*<p><b>IMS refers to I</b>ntercontinental Marketing Services.</p

Averted HIV deaths in British Columbia, Ontario and Quebec, 1995–2008.

<p><b>Panel A</b>: Number of averted deaths per year with 95% CIs. <b>Panel B</b>: The rate of averted deaths per year with 95% CIs.</p

Results from the predictive model for the probability of mortality based on the programmatic compliance score.

<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0047859#s3" target="_blank">Results</a> from the predictive model for the probability of mortality based on the programmatic compliance score.</p

Kaplan Meier estimates for the probability of mortality by the levels of the programmatic compliance score.

<p>Kaplan Meier estimates for the probability of mortality by the levels of the programmatic compliance score.</p

Characteristics of those infected with HIV in British Columbia, Ontario and Quebec, 2008.

<p>Characteristics of those infected with HIV in British Columbia, Ontario and Quebec, 2008.</p